Skip to content

Clinical trials

Multiple Myeloma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Austria Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20022
20031
20041
20052
20064
20071
20081
20092
20106
20114
20125
20132
20143
20156
20161
20178
20181
20193
20202
20214
20227
20238
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Active, not recruiting14
Recruiting11
Terminated4
Unknown status3
Withdrawn1
No longer available1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene13
Amgen8
Janssen Research & Development, LLC6
Bristol-Myers Squibb5
Austrian Forum Against Cancer4
Pfizer4
Arbeitsgemeinschaft medikamentoese Tumortherapie3
European Myeloma Network B.V.3
Millennium Pharmaceuticals, Inc.3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma89
Recurrence12
Neoplasms6
Neoplasms, Plasma Cell4
Bone Marrow Neoplasms2
Hematologic Diseases2
Lymphoma2
Paraproteinemias2
Renal Insufficiency2
Smoldering Multiple Myeloma2

Trials

Showing 76 to 89 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.